These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder]. György B, Robert K, László C, Andrea J, Ketilept Vizsgáló Munkacsoport. Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015 [Abstract] [Full Text] [Related]
5. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. Lee KU, Jeon YW, Lee HK, Jun TY. Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454 [Abstract] [Full Text] [Related]
7. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia]. Beszłej JA, Grzesiak M. Psychiatr Pol; 2005 Aug; 39(2):293-307. PubMed ID: 15881624 [Abstract] [Full Text] [Related]
8. Rapid dose titration of quetiapine for the treatment of acute schizophrenia and acute mania: a case series. Pajonk FG, Schwertner AK, Seelig MA. J Psychopharmacol; 2006 Jan; 20(1):119-24. PubMed ID: 16204326 [Abstract] [Full Text] [Related]
9. Switching to quetiapine in patients with acute mania who were intolerant to risperidone. Pae CU, Lee KU, Kim JJ, Lee CU, Bahk WM, Lee SJ, Lee C, Paik IH. Hum Psychopharmacol; 2004 Jan; 19(1):47-51. PubMed ID: 14716712 [Abstract] [Full Text] [Related]
12. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. Paleacu D, Barak Y, Mirecky I, Mazeh D. Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256 [Abstract] [Full Text] [Related]
13. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group. Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587 [Abstract] [Full Text] [Related]
14. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia. Nasrallah HA, Tandon R. J Clin Psychiatry; 2002 Jun; 63 Suppl 13():12-20. PubMed ID: 12562142 [Abstract] [Full Text] [Related]
15. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years. Berger GE, Proffitt TM, McConchie M, Kerr M, Markulev C, Yuen HP, O'Donnell C, Lubman D, Polari A, Wood S, Amminger PG, McGorry PD. J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233 [Abstract] [Full Text] [Related]
16. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study. Boidi G, Ferro M. Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936 [Abstract] [Full Text] [Related]
18. Quetiapine in combination with citalopram in patients with unipolar psychotic depression. Konstantinidis A, Hrubos W, Nirnberger G, Windhager E, Lehofer M, Aschauer H, Kasper S. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):242-7. PubMed ID: 16962224 [Abstract] [Full Text] [Related]
19. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS, Konarski JZ, Jones M, Paulsson B. J Affect Disord; 2007 Jan 30; 100 Suppl 1():S5-14. PubMed ID: 17391773 [Abstract] [Full Text] [Related]